Thai government signs procurement deal for 2 million Paxlovid tablets

Thailand’s Department of Medical Services has signed a cope with Pfizer to purchase 2 million Paxlovid tablets for the remedy of Covid-19. This equates to 50 treatment programs of the anti-viral medicine, with delivery expected next month, according to a Thai PBS World report.
DMS director Dr. Somsak Akksilp says that medical trials have proven the drug can cut back the chance of hospitalisation or death from sickness by about 88% if given inside 5 days of signs appearing. He provides that its success rate means the US National Institutes of Health has prioritised it over different Covid-19 remedies.
The remedy is a combination of two antiviral medicines, nirmatrelvir and ritonavir. Treatment consists of three pills, 1 of ritonavir, which was as soon as used to treat HIV an infection and AIDS, and 2 of nirmatrelvir, which prevents the Covid-19 protein from replicating. In scientific trials, only 0.77% of Covid patients handled with Paxlovid required hospitalisation and there were no deaths reported. 6.31% of those who received a placebo were hospitalised and thirteen died.
According to Don’t worry , Paxlovid ought to be given to high-risk Covid-19 sufferers who haven’t but developed signs or who solely have mild symptoms. People within the high-risk category embody these over the age of 60 and people with underlying health circumstances, corresponding to diabetes, persistent kidney illness, coronary heart illness, and people with compromised immune systems.
The DMS is currently using 2 other antiviral remedies in Covid-19 patients, molnupiravir and favipiravir, and took supply of another 2 million molnupiravir tablets over every week in the past.
SOURCE: Thai PBS World

Leave a Comment